PRTA

8.1602.86%
SM

Shane Martin Cooke

Independent Director

Mr. Shane Martin Cooke served as Non-Executive Director of Inizio (formerly known as UDG Healthcare plc) since February 1, 2019 and was its Chairman since October 1, 2020. He has been a Non-Executive Director for Alkermes Plc since March 30, 2018. He has extensive experience in the pharmaceutical and life sciences sectors in both Europe and the United States. Mr. Cooke served as the President of Alkermes Plc since September 16, 2011 to March 2018. Mr. Cooke served as an Executive Vice President of Elan Drug Technologies Inc. since May 2007. He served as an Executive Vice President and Head of Elan Drug Technologies (EDT) at Elan Corporation Limited (Alternate name, Elan Corporation, plc) from July 2001 to September 15, 2011 and from May 2007 to September 15, 2011 respectively. He served as the Chief Financial Officer of Elan Corporation Limited from July 2001 to May 2011. He served as the Chief Executive Officer of Pembroke Capital Limited, an aviation leasing company of which he founded. He held several senior positions in finance in the banking and aviation industries. He served as an Executive Director at Elan Corporation Limited from May 31, 2005 to September 15, 2011. He has been a Non-Executive Independent Director of Prothena Corporation plc since December 2012. He served as Independent Director at Endo International plc since July 30, 2014. Mr. Cooke serves as a Director of Perrigo Finance Unlimited Company. Co. Mr. Cooke is a Chartered Accountant. Mr. Cooke earned his Bachelor of Commerce and Master of Accounting degrees from University College Dublin.

公司职务